Global patent landscape of synthetic drugs for melasma (2015-2025): innovation trends, mechanistic shifts, and translational challenges.
- DOI
- 10.1080/13543776.2026.2726449
- Published
- 2026 Sep 14
- Container
- Expert opinion on therapeutic patents
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/13543776.2026.2726449,
title = {Global patent landscape of synthetic drugs for melasma (2015-2025): innovation trends, mechanistic shifts, and translational challenges.},
author = {Torres S and Aragón Novoa DM and Teixeira de Alencar Filho JM and Alves IA},
year = {2026},
journal = {Expert opinion on therapeutic patents},
doi = {10.1080/13543776.2026.2726449},
url = {https://doi.org/10.1080/13543776.2026.2726449}
}RIS
TY - JOUR TI - Global patent landscape of synthetic drugs for melasma (2015-2025): innovation trends, mechanistic shifts, and translational challenges. AU - Torres S AU - Aragón Novoa DM AU - Teixeira de Alencar Filho JM AU - Alves IA PY - 2026 JO - Expert opinion on therapeutic patents DO - 10.1080/13543776.2026.2726449 UR - https://doi.org/10.1080/13543776.2026.2726449 ER -
APA
S, T., DM, A. N., JM, T. D. A. F., & IA, A. (2026). Global patent landscape of synthetic drugs for melasma (2015-2025): innovation trends, mechanistic shifts, and translational challenges.. Expert opinion on therapeutic patents. https://doi.org/10.1080/13543776.2026.2726449
Source records
- pubmed · retrieved 2026-09-25T19:56:55.613Z